346 related articles for article (PubMed ID: 28643424)
1. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.
Tang H; Lei CT; Ye C; Gao P; Wan C; Chen S; He FF; Wang YM; Su H; Zhang C
J Cell Mol Med; 2017 Dec; 21(12):3435-3444. PubMed ID: 28643424
[TBL] [Abstract][Full Text] [Related]
2. Podocyte loss involves MDM2-driven mitotic catastrophe.
Mulay SR; Thomasova D; Ryu M; Kulkarni OP; Migliorini A; Bruns H; Gröbmayr R; Lazzeri E; Lasagni L; Liapis H; Romagnani P; Anders HJ
J Pathol; 2013 Jul; 230(3):322-35. PubMed ID: 23749457
[TBL] [Abstract][Full Text] [Related]
3. MAD2B contributes to podocyte injury of diabetic nephropathy via inducing cyclin B1 and Skp2 accumulation.
Su H; Wan Q; Tian XJ; He FF; Gao P; Tang H; Ye C; Fan D; Chen S; Wang YM; Meng XF; Zhang C
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F728-36. PubMed ID: 25651564
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
5. Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis.
Feng J; Xie L; Lu W; Yu X; Dong H; Ma Y; Kong R
Ren Fail; 2024 Dec; 46(2):2365408. PubMed ID: 38874119
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination-dependent CARM1 degradation facilitates Notch1-mediated podocyte apoptosis in diabetic nephropathy.
Kim D; Lim S; Park M; Choi J; Kim J; Han H; Yoon K; Kim K; Lim J; Park S
Cell Signal; 2014 Sep; 26(9):1774-82. PubMed ID: 24726896
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
8. MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway.
Ye C; Tang H; Zhao Z; Lei CT; You CQ; Zhang J; Gao P; He FF; Chen S; Wang YM; Zhang C; Su H
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F760-F768. PubMed ID: 28100501
[TBL] [Abstract][Full Text] [Related]
9. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
[No Abstract] [Full Text] [Related]
10. Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis.
Wang XM; Yao M; Liu SX; Hao J; Liu QJ; Gao F
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F205-13. PubMed ID: 24226527
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria.
Nishad R; Mukhi D; Singh AK; Motrapu M; Chintala K; Tammineni P; Pasupulati AK
Cell Death Dis; 2021 Apr; 12(4):342. PubMed ID: 33795655
[TBL] [Abstract][Full Text] [Related]
12. MDM2 Contributes to High Glucose-Induced Glomerular Mesangial Cell Proliferation and Extracellular Matrix Accumulation via Notch1.
Lei CT; Tang H; Ye C; You CQ; Zhang J; Zhang CY; Xiong W; Su H; Zhang C
Sci Rep; 2017 Sep; 7(1):10393. PubMed ID: 28871126
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
Liu Y; Xu Z; Ma F; Jia Y; Wang G
Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
[TBL] [Abstract][Full Text] [Related]
14. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
15. Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.
Thomasova D; Bruns HA; Kretschmer V; Ebrahim M; Romoli S; Liapis H; Kotb AM; Endlich N; Anders HJ
J Am Soc Nephrol; 2015 Jul; 26(7):1513-23. PubMed ID: 25349197
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
18. APPL1 acts as a protective factor against podocytes injury in high glucose environment.
Ji Z; Hu Z; Xu Y
Int J Clin Exp Pathol; 2015; 8(6):6764-71. PubMed ID: 26261560
[TBL] [Abstract][Full Text] [Related]
19. MiR-33a Overexpression Exacerbates Diabetic Nephropathy Through Sirt6-dependent Notch Signaling.
Wang Y; Dai S; Yang J; Ma J; Wang P; Zhao X; Liu J; Xiao A; Song Y; Gao L
Iran J Kidney Dis; 2024 May; 18(3):168-178. PubMed ID: 38904337
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
Nishad R; Mukhi D; Tahaseen SV; Mungamuri SK; Pasupulati AK
J Biol Chem; 2019 Nov; 294(44):16109-16122. PubMed ID: 31511328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
